Abstract
Rationale:
Injection-related abscesses are a common complication in clinical practice, but the identification of infected bacteria might be difficult.
Patient concerns:
A 51-year-old female patient was admitted to the hospital due to a lump on her right buttock that emerged after receiving intramuscular injections to treat left shoulder joint pain. The lump gradually enlarged into a 3.0 to 4.5 cm mass at the time of admission with symptoms such as skin redness, itching, and pain.
Diagnoses:
The patient received ultrasonic and other laboratory examinations. Laboratory results from the drainage indicated that the infection was caused by a rapidly growing mycobacteria and was confirmed as Mycobacterium fortuitum by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry.
Interventions:
The patient was treated with antibiotics for 12 days after incision and drainage of the abscess in the right buttock. Local dressings were changed regularly. A migration lesion that appeared 3 days after treatment was drained and cleaned when it matured.
Outcomes:
The lesion substantially decreased in size and the patient was discharged after 2 months of treatment.
Lessons:
Rapidly growing mycobacteria are rare but important pathogens that should be considered in patients with injection-related abscesses. Early identification and appropriate treatment can result in a favorable prognosis.
Keywords: abscess, case report, infection, Mycobacterium fortuitum
1. Introduction
Mycobacterium fortuitum is widely present in the natural environment and is classified as group IV of nontuberculous mycobacteria (NTM). NTMs are opportunistic pathogen that can cause various infections, including skin and soft tissue infections, pulmonary infections, and disseminated infections in immunocompromised individuals.[1–5] Skin and soft tissue infections caused by NTMs often occur after surgery, trauma, or injection.[6] As a subgroup of NTMs, M fortuitum is characterized by its weak pathogenicity, non-toxin production, high tolerance and rapid growth compared to other NTM members.[1] Thus, the infections caused by M fortuitum can be difficult to diagnose, as the early symptoms are not obvious, and the detection rate of routine culture is low. In primary hospitals, they are often classified as NTMs and cannot carry out intergeneric identification or drug sensitivity tests due to the lack of molecular biology, gene chips and other detection methods, which makes the subsequent treatment difficult. The use of mass spectrometer makes the identification of NTM simple and rapid. Here we report a case of rapid identification of M fortuitum using a mass spectrometer.
2. Case presentation
A 51-year-old female patient was admitted to the hospital due to a lump on her right buttock that had been present for 1 month. The lump emerged after she had received 4 intramuscular injections including vitamin B12, tanshinones, vitamin K, and other drugs at a private clinic to treat left shoulder joint pain. The injections were administered into the right buttock muscles over a period of 15 days. Following the injections, a spherical hard lump with clear borders appeared at the injection site, without redness or obvious tenderness. The lumpgradually became soft and enlarged into a 3.0 to 4.5 cm mass 35 days after the first discovery, along with symptoms such as skin redness, itching, and pan. The patient self-administered various medications, including spiramycin tablets, Sanjie tablets, amoxicillin capsules, and Xiaoyao pills, to treat the symptoms, but with no relief, and in contrast the area of redness and local pain increased.
An ultrasonic examination revealed a thickened subcutaneous fat area in the right upper outer buttocks, with enhanced echo and an irregular liquid dark areameasuring approximately 6.3 × 3.2 × 3.3 cm. Granular substance could be seen when the area was pressed. No obvious abnormalities were found in peripheral blood or other routine tests, including coagulation or liver or kidney functions.
One day following admission, the patient underwent an incision to drain the abscess in the right buttock under local anesthesia, resulting in a drainage of about 70 mL of thick yellow pus without noticeable peculiar odor. The abscess cavity was rinsed with hydrogen peroxide and normal saline, after which a drainage tube was placed to drain the pus, and a sterile cotton pad was used to cover the wound. Local dressings were changed daily. The patient received intravenous administration of piperacillin/tazobactam (4.5 g per 8 hours) and ornidazole (0.5g per 12 hours). After 3 days of treatment, a new induration was formed 5 cm directly below the original abscess site, which was considered as a migration lesion from the initial site (Fig. 1). After the new lesion matured, the necrotic tissue was removed, and the sinus was cleaned. The anti-infection treatment was continued for 12 days, and the local dressings were changed every 2 days a month later.
Figure 1.
Left, initial (top) and new metastatic (bottom) lesions after incision drainage of the primary lesion. Right, two month after treatment.
The pus sample was inoculated onto blood agar, MacConkey agar, and chocolate agar plates respectively and incubated at 35°C. Additionally, 2 slides were prepared for staining with the pus sample. After 72 hours, small colonies were observed on the blood agar and chocolate agar plates. These colonies appeared as short bacilli with weak Gram staining (Fig. 2) and acid-fast positive when stained with the Ziehl–Neelsen (Fig. 3). A small number of acid-fast positive short rods were also observed on the direct-smeared slides.
Figure 2.
Weakly Gram stained bacilli detected from the pus sample.
Figure 3.
Acid-fast staining shows rod-shaped red bacteria.
The colonies grew gradually over the following 5 days to a diameter of 0.5 to 1 mm with a white, moist, and smooth appearance. By day 7, the white colonies had increased to approximately 2 to 3 mm in diameter and exhibited a round, smooth, and petal-shaped morphology (Fig. 4). No bacterial growth was discovered in ordinary and anaerobic cultures. The bacteria showed positive results in the MacConkey agar culture, arylsulfatase test, 68°C catalase test, urease test, nitrate reduction test, and NaCl tolerance test. Negative results were obtained for the utilization of mannitol, sorbitol, inositol, and citrate salts.
Figure 4.
Colony morphology after 7 days of cultivation.
Thus, based on the growth rate, pigment production, enzyme activity, and growth on different media, the bacteria were consistent with the characteristics of rapidly growing mycobacteria, which are the majority of NTM infections reported in China.[7–9] They were further identified as M fortuitum (> 99.9%, Fig. 5) using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (Biomerieux, France). Minimal inhibitory concentration testing revealed that the bacteria were sensitive to amikacin, gentamicin, ciprofloxacin, levofloxacin, and clarithromycin but resistant to erythromycin, penicillin, ampicillin, cefotaxime, vancomycin, and co-trimoxazole.
Figure 5.
The colony was identified as Mycobacterium fortuitum by mass spectrometry. Top, the output of the MS; bottom, raw spectral fingerprints obtained from the colony.
After reviewing the laboratory results, the treatment plan was deemed effective and continued. Following 2 months of continuous treatment, the lesion substantially decreased in size, as shown in Figure 2 (right). As a result, the patient was discharged from the hospital in a stable condition and follow-up appointments were scheduled to monitor the healing progress.
3. Discussion
The clinical signs of M fortuitum infection varies widely, ranging from localized abscesses to systemic infections. In our patient’s case, the infection presented as a rapidly enlarging abscess in the right buttock, which was initially treated with incision and drainage. However, a new lesion appeared after 3 days oftreatment, which was considered a migration lesion from the initial site. This phenomenon is not uncommon in NTM infections, and it highlights the importance of a thorough evaluation of the patient for successful treatment.
Diagnosis of M fortuitum infection can be challenging, as it is a fastidious organism that requires special culture techniques and prolonged incubation periods for growth. Acid-fast staining and molecular methods such as polymerase chain reaction can aid in the diagnosis of M fortuitum infection. In our patient’s case, the diagnosis was confirmed by culturing the pus on specific media and subsequent identification by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Treatment of NTM infection is challenging, as it is often resistant to multiple antibiotics, has a long duration, and is prone to relapse.[10] Antimicrobial susceptibility testing is essential to guide appropriate treatment, and a combination of antibiotics is often necessary to achieve a successful outcome.[11,12] In our patient’s case, the organism was sensitive to amikacin, gentamicin, ciprofloxacin, levofloxacin, and clarithromycin, and the patient was treated with a combination of piperacillin/tazobactam and ornidazole, which effectively improved the patient’s symptoms.
It is noteworthy that the resistance of M fortuitum strains varies geographically, and the choice of antibiotics should be based on local antimicrobial susceptibility data. A study by Zheng et al[13] has shown that in China, the resistance of M fortuitum strain is lower to moxifloxacin and amikacin, but significantly higher to macrolides, compared to that reported in the studies by Shahraki et al, and Gleeson et al[5,14] This might be related to the frequent use of macrolides by Chinese doctors to treat respiratory mycoplasma infections, leading to increased exposure to the drug.[15,16]
4. Conclusion
M fortuitum infection should be considered in patients presenting with skin and soft tissue infections, especially after injections, surgery, or trauma. A thorough evaluation, including appropriate diagnostic testing and antimicrobial susceptibility testing, is essential to guide appropriate treatment and prevent recurrence. The choice of antibiotics should be based on local susceptibility data, and a combination of antibiotics may be necessary for successful treatment.
Author contributions
Data curation: Tao Zhang, Hao Li.
Formal analysis: Tao Zhang, Hao Li.
Investigation: Tao Zhang, Hao Li.
Methodology: Tao Zhang, Hao Li.
Project administration: Hao Li.
Resources: Hao Li.
Supervision: Hao Li.
Validation: Tao Zhang.
Writing – original draft: Tao Zhang.
Writing – review & editing: Hao Li, Tao Zhang.
Abbreviation:
- NTM
- nontuberculous mycobacteria
The datasets generated during and/or analyzed during the current study are publicly available.
TZ and HL contributed equally to this work.
The patient provided written informed consent (submitted) for publication of the case.
The authors have no funding and conflicts of interest to disclose.
How to cite this article: Li H, Zhang T. A case report of Mycobacterium fortuitum infection after muscle injection. Medicine 2023;102:48(e36060).
References
- [1].Brown-Elliott BA, Wallace RJ, Jr. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev. 2002;15:716–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].Bartralot R, Pujol RM, García-Patos V, et al. Cutaneous infections due to nontuberculous mycobacteria: histopathological review of 28 cases comparative study between lesions observed in immunosuppressed patients and normal hosts. J Cutan Pathol. 2000;27:124–9. [DOI] [PubMed] [Google Scholar]
- [3].Ena P, Sechi LA, Saccabusi S, et al. Rapid identification of cutaneous infections by nontubercular mycobacteria by polymerase chain reaction-restriction analysis length polymorphism of the hsp65 gene. Int J Dermatol. 2001;40:495–9. [DOI] [PubMed] [Google Scholar]
- [4].Katoch VM. Infections due to non-tuberculous mycobacteria (NTM). Indian J Med Res. 2004;120:290–304. [PubMed] [Google Scholar]
- [5].Gleeson LE, Waterer G. Beyond antibiotics: recent developments in the diagnosis and management of nontuberculous mycobacterial infection. Breathe (Sheff). 2022;18:210171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Atkins BL, Gottlieb T. Skin and soft tissue infections caused by nontuberculous mycobacteria. Curr Opin Infect Dis. 2014;27:137–45. [DOI] [PubMed] [Google Scholar]
- [7].Fei Y, Xiao C, Zhongkang J, et al. Prevalence of Nontuberculous mycobacteriain hangzhou during 2009–2014. Chin J Microecol. 2016;28:808–810, 815. [Google Scholar]
- [8].He GQ, Xu K, San ZC, et al. Prevalence of nontuberculous mycobacteria isolated from pulmonary specimens in Wenzhou during 2014–2016. Chin J Clin Infect Dis. 2017;10:262–7. [Google Scholar]
- [9].Luo CM, Zhou GM, Liu GJ, et al. Analysis of identification results of non-tuberculous mycobacteria in Guangzhou from 2003–2012. J Tuberculosis Lung Dis. 2014;3:15–20. [Google Scholar]
- [10].Fok E, Verma A, Pratim P, et al. The profile of non-tuberculous mycobacteria (NTM) and clinical characteristics of patients in Singapore. Respirology. 2016;21:62–62. [Google Scholar]
- [11].Qin ZH, Jin Y, Du YQ, et al. Spectrum and drug resistance analysis of 339 strains of nontuberculous mycobacterium isolated from clinical practice. Chinese J Antituberculosis. 2020;42:630–3. [Google Scholar]
- [12].Li YM, Tong XL, Xu HT, et al. Prevalence and antimicrobial susceptibility of mycobacterium abscessus in a General Hospital, China. Biomed Environ Sci. 2016;29:85–90. [DOI] [PubMed] [Google Scholar]
- [13].Zheng HW, Pang Y, He GX, et al. Antimicrobial susceptibility testing and molecular characterization of Mycobacterium fortuitum isolates in China. Biomed Environ Sci. 2017;30:376–9. [DOI] [PubMed] [Google Scholar]
- [14].Heidarieh P, Mirsaeidi M, Hashemzadeh M, et al. In vitro antimicrobial susceptibility of nontuberculous mycobacteria in Iran. Microb Drug Resist. 2016;22:172–8. [DOI] [PubMed] [Google Scholar]
- [15].Chen JH, Yin GQ, Yu JL, et al. Clinical effect of erythromycin and azithromycin in the treatment of pediatric mycoplasma pneumonia. Chin J Clin Pharmacology. 2015;8:587–9. [Google Scholar]
- [16].Liu JR, Peng Y, Yang HM, et al. Clinical characteristics and predictive factors of refractory mycoplasma pneumoniae pneumonia. Chin J Pediatr. 2012;50:915–8. [PubMed] [Google Scholar]





